Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Survival Outcomes of Multiple Myeloma Patients Admitted on Assiut Clinical Hematology Unit
ClinicalTrials.gov study NCT05119205. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00270101. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Japan Phase I/II Study of Bortezomib in Relapsed or Refractory Multiple Myeloma Patients
ClinicalTrials.gov study NCT00752518. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study on the Use of Sulpegfilgrastim to Prevent the Incidence of Neutropenia With Infection in Newly Diagnosed Non-transplant Multiple Myeloma Patients
ClinicalTrials.gov study NCT07018271. IPD Sharing: YES. Countries: 0. Publications: 0.
Samarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant
ClinicalTrials.gov study NCT00602706. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00085345. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Superiority of VCD Versus CTD in Patients With Newly Diagnose Multiple Myeloma Eligible for Transplantation
ClinicalTrials.gov study NCT03402295. IPD Sharing: NO. Countries: 0. Publications: 0.
A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00096837. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Benefits of Adapted Physical Activity for Chronic Osteoarticular Pain in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT05548686. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Mezigdomide Plus Ixazomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06050512. IPD Sharing: NO. Countries: 0. Publications: 0.
Cost-Utility Analysis of Home-based Versus Hospital-based Chemotherapy in Multiple Myeloma: Case of Carfilzomib
ClinicalTrials.gov study NCT05184595. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma.
ClinicalTrials.gov study NCT00242528. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Busulfan in Multiple Myeloma
ClinicalTrials.gov study NCT00934232. IPD Sharing: NO. Countries: 0. Publications: 0.
CAR-T Cell Therapy Combined With Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06913179. IPD Sharing: NO. Countries: 0. Publications: 0.
A Study to Further Assess Safety and Effectiveness Data of the Bortezomib(Velcade)/Melphalan/Prednisone (BMP) Regimen in Previously Untreated and Transplant Ineligible Multiple Myeloma Patients
ClinicalTrials.gov study NCT00799539. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Institut Paoli Calmettes Multiple Myeloma Database
ClinicalTrials.gov study NCT02869555. IPD Sharing: NO. Countries: 1. Publications: 0.
A Single-centre Prospective Study to Explore the Role of Frailty in Patients With Multiple Myeloma.
ClinicalTrials.gov study NCT04683393. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Study of SYS6020 in BCMA-positive Multiple Myeloma
ClinicalTrials.gov study NCT06359509. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Evaluation of the Safety of Oncocort IV Pegylated Liposomal Dexamethasone Phosphate in Patients With Progressive Multiple Myeloma
ClinicalTrials.gov study NCT03033316. IPD Sharing: NO. Countries: 0. Publications: 0.
Fluciclovine PET/CT in Multiple Myeloma Patients
ClinicalTrials.gov study NCT03966443. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.